Intellia Therapeutics (NTLA) said late Monday it launched a public offering of $150 million of common shares.
The company said it will grant the underwriters a 30-day overallotment option to buy up to an additional 15% of the shares offered.
Intellia Therapeutics (NTLA) said late Monday it launched a public offering of $150 million of common shares.
The company said it will grant the underwriters a 30-day overallotment option to buy up to an additional 15% of the shares offered.
Comments